{
    "title": "'Bone risk' blow for Glaxo diabetes drug",
    "url": "https://www.dailymail.co.uk/money/markets/article-1611650/Bone-risk-blow-for-Glaxo-diabetes-drug.html",
    "date": "2007-07-03",
    "keywords": [
        "study",
        "drug",
        "avandia",
        "risk",
        "journal",
        "glaxo",
        "bone",
        "blow",
        "report",
        "heart",
        "year",
        "company",
        "trial",
        "money",
        "gmt",
        "july",
        "view",
        "glaxosmithkline",
        "disaster",
        "medicine",
        "disease",
        "publication",
        "cornerstone",
        "glaxos",
        "business",
        "group",
        "patient",
        "retrospective",
        "rule",
        "age",
        "duration",
        "spokesman",
        "stanley",
        "significance",
        "labelling",
        "sentiment",
        "investment",
        "bank",
        "care",
        "evidence",
        "reduction",
        "density",
        "one",
        "issue",
        "background",
        "england",
        "review",
        "regulator",
        "food",
        "administration",
        "approval",
        "process",
        "controversy",
        "overhaul",
        "companys",
        "director",
        "dr",
        "ronald",
        "krall",
        "completion"
    ],
    "category": [
        "money",
        "markets"
    ]
}